SCLXW Scilex Holding Company
$0.11▲ +1.10%
Healthcare
Other
Volume 7.7K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.06 - 0.11
% vs 50 MA
-24.44%
% vs 200 MA
–%
RSI-14
44.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.60
Free Cash Flow
-$4.58M
Gross Rev
$7.64M
Gross Profit
$3.97M
EBITDA
-$83.06M
COGS
$3.68M
Operating Exp
$33.39M
Operating Income
-$29.42M
EBIT
-$29.42M
Pretax Income
-$114.98M
Net Income
-$113.50M
Price & Volume History
Loading chart…
Recent News
Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.
CNW Group · Aug 20, 2026 8:12 PM
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
GlobeNewswire · Jul 7, 2026 10:00 AM
Scilex, Vera Therapeutics rise premarket; Strategy gains
Investing.com · Jul 6, 2026 12:19 PM
Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)
InvestorsHub · Jul 6, 2026 11:33 AM
Scilex Agrees to Sell $100 Million in Newly Issued Shares to Kazakhstan-Based iHolding
MT Newswires · Jul 6, 2026 10:43 AM
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
GlobeNewswire · Jul 6, 2026 10:00 AM
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
PR Newswire · Jun 25, 2026 3:35 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SCLXW's money flow as a full page
Social Sentiment
No Reddit posts found for SCLXW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.